Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2014 1
2015 1
2016 1
2017 2
2018 3
2019 5
2020 2
2021 1
2022 2
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Corrigendum: FXYD5/Dysadherin, a biomarker of endometrial cancer myometrial invasion and aggressiveness: its relationship with TGF-β1 and NF-κB pathways.
Besso MJ, Rosso M, Lapyckyj L, Moiola CP, Matos ML, Mercogliano MF, Schillaci R, Reventos J, Colas E, Gil-Moreno A, Wernicke A, Orti R, Vazquez-Levin MH. Besso MJ, et al. Front Oncol. 2024 Jan 23;13:1322204. doi: 10.3389/fonc.2023.1322204. eCollection 2023. Front Oncol. 2024. PMID: 38322279 Free PMC article.
Noninvasive detection of microsatellite instability in patients with endometrial cancer.
Casas-Arozamena C, Moiola CP, Vilar A, Bouso M, Cueva J, Cabrera S, Sampayo V, Arias E, Abalo A, García Á, Lago-Lestón RM, Oltra S, Díaz E, Ruiz-Bañobre J, López-López R, Moreno-Bueno G, Gil-Moreno A, Colás E, Abal M, Muinelo-Romay L. Casas-Arozamena C, et al. Int J Cancer. 2023 May 15;152(10):2206-2217. doi: 10.1002/ijc.34435. Epub 2023 Jan 24. Int J Cancer. 2023. PMID: 36650670
Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression.
Mota A, Oltra SS, Selenica P, Moiola CP, Casas-Arozamena C, López-Gil C, Diaz E, Gatius S, Ruiz-Miro M, Calvo A, Rojo-Sebastián A, Hurtado P, Piñeiro R, Colas E, Gil-Moreno A, Reis-Filho JS, Muinelo-Romay L, Abal M, Matias-Guiu X, Weigelt B, Moreno-Bueno G. Mota A, et al. Among authors: moiola cp. Oncogene. 2022 Mar;41(13):1835-1850. doi: 10.1038/s41388-022-02221-0. Epub 2022 Feb 10. Oncogene. 2022. PMID: 35145232 Free PMC article.
Modeling ANXA2-overexpressing circulating tumor cells homing and high throughput screening for metastasis impairment in endometrial carcinomas.
Herrero C, Brea J, Pérez-Díaz A, Cuadrado E, Ferreño N, Moiola CP, Colás E, Gil-Moreno A, López-López R, Loza MI, Abal M, Alonso-Alconada L. Herrero C, et al. Biomed Pharmacother. 2021 Aug;140:111744. doi: 10.1016/j.biopha.2021.111744. Epub 2021 May 25. Biomed Pharmacother. 2021. PMID: 34049223 Free article.
Genomic Profiling of Uterine Aspirates and cfDNA as an Integrative Liquid Biopsy Strategy in Endometrial Cancer.
Casas-Arozamena C, Díaz E, Moiola CP, Alonso-Alconada L, Ferreirós A, Abalo A, Gil CL, Oltra SS, de Santiago J, Cabrera S, Sampayo V, Bouso M, Arias E, Cueva J, Colas E, Vilar A, Gil-Moreno A, Abal M, Moreno-Bueno G, Muinelo-Romay L. Casas-Arozamena C, et al. J Clin Med. 2020 Feb 21;9(2):585. doi: 10.3390/jcm9020585. J Clin Med. 2020. PMID: 32098121 Free PMC article.
22 results